Ki Summary

Reaction Details

Report a problem with these data

Target

Somatostatin receptor type 2

Ligand

BDBM50075277

Substrate/Competitor

n/a

Meas. Tech.

ChEBML_200682

11±n/a nM

Citation

Pasternak, A; Pan, Y; Marino, D; Sanderson, PE; Mosley, R; Rohrer, SP; Birzin, ET; Huskey, SE; Jacks, T; Schleim, KD; Cheng, K; Schaeffer, JM; Patchett, AA; Yang, L Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization. Bioorg Med Chem Lett9:491-6 (1999) [PubMed]

More Info.:

Get all data from this article, Assay Method

Somatostatin receptor type 2

Name:

Somatostatin receptor type 2

Synonyms:

Type:

Enzyme

Mol. Mass.:

41344.94

Organism:

Homo sapiens (Human)

Description:

P30874

Residue:

369

Sequence:

MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCG
NTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMT
VDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIY
AGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGI
RVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVL
TYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTL
LNGDLQTSI

BDBM50075277

n/a

Name

BDBM50075277

Synonyms:

(2R,3S)-N-(5-Amino-[1,3]dioxan-2-ylmethyl)-3-(1H-indol-3-yl)-N-methyl-2-[2-oxo-3-(3-phenyl-propyl)-imidazolidin-1-yl]-butyramide | CHEMBL356717

Type

Small organic molecule

Emp. Form.

C30H39N5O4

Mol. Mass.

533.6618

SMILES

C[C@H]([C@@H](N1CCN(CCCc2ccccc2)C1=O)C(=O)N(C)C[C@H]1OC[C@H](N)CO1)c1c[nH]c2ccccc12 |wU:2.2,23.24,wD:26.28,1.0,(-1.32,3.36,;-1.3,1.82,;.03,1.05,;1.36,1.84,;1.36,3.38,;4.03,3.39,;4.03,1.85,;5.39,1.09,;6.71,1.87,;8.05,1.11,;9.38,1.89,;9.36,3.43,;10.69,4.2,;12.03,3.45,;12.05,1.91,;10.72,1.12,;2.7,1.07,;2.72,-.48,;.03,-.48,;1.59,-.49,;-.74,-1.81,;-2.28,-1.8,;.01,-3.16,;-.76,-4.47,;.01,-5.83,;-.79,-7.16,;-2.33,-7.14,;-3.13,-8.47,;-3.08,-5.8,;-2.31,-4.47,;-2.63,1.04,;-2.63,-.5,;-3.97,-1.29,;-5.3,-.51,;-6.63,-1.29,;-7.97,-.51,;-7.97,1.03,;-6.63,1.82,;-5.3,1.04,)|

Structure